St. Jude Medical Center is a faith-based, not-for-profit hospital, located in Fullerton, California, which was established by the Sisters of St. Joseph of Orange in 1957.

There are 320 beds in Saint Jude Medical Center.

During the past decade, Saint Jude Medical Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 39 clinical trials were completed, i.e. on average, 156% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 23 clinical trials were completed. i.e. 230% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Jude Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "Alliance for Clinical Trials in Oncology" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Jude Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Saint Jude Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Saint Jude Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Jude Medical Center" are "Drug" (49 trials), "Other" (34 trials), "Biological" (18 trials), "Device" (10 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (11 trials), "Placebo" (10 trials), "Docetaxel" (6 trials) and "Bevacizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Saint Jude Medical Center" are 63 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Saint Jude Medical Center". undefined are not yet recruiting, 9 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Saint Jude Medical Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Jude Medical Center, 3 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".